RANTES promotes growth and survival of human first-trimester forebrain astrocytes

被引:68
作者
Bakhiet, M [1 ]
Tjernlund, A
Mousa, A
Gad, A
Strömblad, S
Kuziel, WA
Seiger, A
Andersson, J
机构
[1] Huddinge Univ Hosp, Karolinska Inst, Dept Med, Ctr Infect Med, SE-14186 Stockholm, Sweden
[2] Huddinge Univ Hosp, Karolinska Inst, Dept Clin Neurosci, Div Geriatr Med, SE-14186 Stockholm, Sweden
[3] Huddinge Univ Hosp, Karolinska Inst, Dept Immunol Microbiol & Pathol, Div Pathol, SE-14186 Stockholm, Sweden
[4] Sodertorns Hogskola, Stockholm, Sweden
[5] Univ Texas, Sect Mol Genet & Microbiol, Austin, TX 78712 USA
[6] Univ Texas, Inst Cell & Mol Biol, Austin, TX 78712 USA
关键词
D O I
10.1038/35055057
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We have examined the role of alpha and beta chemokines in the promotion of the ontogenetic development of the brain. RANTES was expressed preferentially in human fetal astrocytes in an age-dependent manner. Astrocytes from 5-week-old brains showed high proliferation and reduced survival, whereas 10-week-old astrocytes exhibited opposite effects. These effects were suppressed by anti-RANTES or anti-RANTES receptor antibodies and were enhanced by recombinant RANTES. RANTES induced tyrosine phosphorylation of several cellular proteins and nuclear translocation of STAT-1 in astrocytes. Interferons (IFN-gamma) was required for RANTES effects because RANTES induced IFN-gamma, and only 10-week-old astrocytes expressed the IFN-gamma receptor. Blocking of IFN-gamma with antibody reversed the effects of RANTES, indicating that cytokine/chemokine networks are critically involved in brain development.
引用
收藏
页码:150 / 157
页数:8
相关论文
共 35 条
[11]   Differential activation of CC chemokine receptors by AOP-RANTES [J].
Elsner, J ;
Mack, M ;
Brühl, H ;
Dulkys, Y ;
Kimmig, D ;
Simmons, G ;
Clapham, PR ;
Schlöndorff, D ;
Kapp, A ;
Wells, TNC ;
Proudfoot, AEI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (11) :7787-7794
[12]   CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia [J].
He, JL ;
Chen, YZ ;
Farzan, M ;
Choe, HY ;
Ohagen, A ;
Gartner, S ;
Busciglio, J ;
Yang, XY ;
Hofmann, W ;
Newman, W ;
Mackay, CR ;
Sodroski, J ;
Gabuzda, D .
NATURE, 1997, 385 (6617) :645-649
[13]  
HOFMAN FM, 1986, J IMMUNOL, V136, P3239
[14]  
JONAKAIT GM, 1994, NEURON, V12, P1149
[15]   Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes [J].
Loetscher, P ;
Seitz, M ;
Baggiolini, M ;
Moser, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :569-577
[16]  
McManus CM, 1998, J IMMUNOL, V160, P1449
[17]   GROWTH-FACTOR REGULATION OF NEURONAL DEVELOPMENT [J].
MEHLER, MF ;
KESSLER, JA .
DEVELOPMENTAL NEUROSCIENCE, 1994, 16 (3-4) :180-195
[18]   INTERACTIONS OF THE NERVOUS AND IMMUNE-SYSTEMS IN DEVELOPMENT, NORMAL BRAIN HOMEOSTASIS, AND DISEASE [J].
MERRILL, JE ;
JONAKAIT, GM .
FASEB JOURNAL, 1995, 9 (08) :611-618
[19]   MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA IN THE CEREBROSPINAL-FLUID OF PATIENTS WITH MULTIPLE-SCLEROSIS AND OTHER INFLAMMATORY NEUROLOGICAL DISEASES [J].
MIYAGISHI, R ;
KIKUCHI, S ;
FUKAZAWA, T ;
TASHIRO, K .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1995, 129 (02) :223-227
[20]  
Mousa A, 1998, INT J MOL MED, V1, P171